Sera Prognostics (SERA) Net Income towards Common Stockholders (2020 - 2026)
Sera Prognostics posted quarterly Net Income towards Common Stockholders of -$8.4 million for Q1 2026, down 1.1% year-on-year from -$8.5 million in Q1 2025, and down 6.39% on a QoQ basis from -$7.9 million in Q4 2025.
Sera Prognostics (SERA) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$8.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 1.1% year-over-year to -$8.4 million; the trailing twelve-month figure through Mar 2026 stood at -$32.4 million (up 4.32% YoY), and the FY2025 full-year result was -$32.3 million, up 4.88% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$8.4 million, down from -$7.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$7.7 million in Q3 2023 and bottomed at -$12.3 million in Q1 2022.
- The 5-year median for Net Income towards Common Stockholders is -$8.4 million (2024), against an average of -$9.4 million.
- The widest annual swing landed in 2022, when Net Income towards Common Stockholders plunged 94.31%; it then jumped 31.09% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$10.4 million in 2022, then increased by 20.6% to -$8.3 million in 2023, then decreased by 5.67% to -$8.8 million in 2024, then grew by 9.56% to -$7.9 million in 2025, then declined by 6.39% to -$8.4 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$8.4 million (Q1 2026), -$7.9 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | -8.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.43 Mn |
| Dec 31, 2025 | -7.92 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -8.13 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Dec 31, 2024 | -8.76 Mn |
| Sep 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.59 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Dec 31, 2023 | -8.29 Mn |
| Sep 30, 2023 | -7.72 Mn |
| Jun 30, 2023 | -11.47 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -11.21 Mn |
| Jun 30, 2022 | -11.76 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -12.55 Mn |
| Sep 30, 2021 | -9.88 Mn |
| Jun 30, 2021 | -7.36 Mn |
| Mar 31, 2021 | -6.33 Mn |
| Dec 31, 2020 | -5.31 Mn |
| Sep 30, 2020 | -5.07 Mn |
| Jun 30, 2020 | -4.70 Mn |